Antikörper-Therapien gegen frühe COVID? Besser abwarten und impfen!

from EvidenzUpdate – für klügere Medizin · host Denis Nößler, Martin Scherer

Nicht nur Impfstoffe, auch mehr und mehr Arzneien werden gegen COVID-19 zugelassen – auch monoklonale Antikörper. Werden sie zum ambulanten Wundermittel? Ein „EvidenzUpdate“ über mAbs.

Episode metadata supplied by the publisher feed · Published Nov 26, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Antikörper-Therapien gegen frühe COVID? Besser abwarten und impfen!

0:00 36:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EvidenzUpdate – für klügere Medizin?

This episode is 36 minutes long.

When was this EvidenzUpdate – für klügere Medizin episode published?

This episode was published on November 26, 2021.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this EvidenzUpdate – für klügere Medizin episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!